CD8A and neoplasm: To determine which type of CAR-T cells contribute more to antitumor effect in vivo, we isolated human CD4+ and CD8+ T cells, polarized them in vitro under Th9- or Th1-culture condition, and injected them into tumor-bearing mice (Supplementary Fig. 8a).